The HOXB13:IL17BR ratio has been reported to predict outcome in early breast cancer patients treated with Tamoxifen [11], thus we evaluated the predictive value of this ratio in our data set using the same approach as previously reported. This evidence concerns the gene IL17RB and breast cancer.